Table 4. Novel non-invasive fibrosis algorithms.
LINKI-1: HA (μg/L) AST (U/L), glucose (mmol/L), age (yrs) | (age x 0.066)+(AST x 0.0888)+(glucose x 0.34)+(HA x 0.019)-24.136 |
LINKI-2a: HA (μg/L), AST (U/L), glucose (mmol/L), age (yrs), Platelet count (x109/L) | HA x AST2 x age x (glucose)/(platelet count) |
LINKI-2b: HA (μg/L), AST (U/L), glucose (mmol/L), age (yrs), platelet count (x109/L) | HA x AST x age x (glucose)2/(platelet count) |
LINKI-2c: HA (μg/L), AST (U/L), glucose (mmol/L), age (yrs), platelet count (x109/L) | HA x AST x age x (glucose)/(√platelet count) |
Abbreviations: LINKI, Linköping University-Karolinska Institute; AST, aspartate aminotransferase; HA, hyaluronic acid